PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmjThis ArticleThe BMJ
 
BMJ. 2007 April 7; 334(7596): 709.
PMCID: PMC1847848
Transparency in NICE

Let's open whole process of cost effective modelling

Jack Dowie, emeritus professor of health impact analysis

The National Institute for Health and Clinical Excellence (NICE) needs to go much further than allowing access to its modelling data.1 The whole cost effectiveness modelling process needs to be opened up to involvement by all stakeholders, and inspection by the public, as it happens. The independent group should be contracted to develop the one and only model that NICE will consider in its appraisal, and it should do so in full and continuous collaboration with all registered stakeholders and interested parties who sign up to the NICE guidelines. The model will be run with any alternative parameters suggested by various parties and the alternative results (along with their evidential basis) submitted to the appraisal committee in a single report. No subsequent questioning of, or submissions regarding, the model structure, the results, or the underlying principles would be accepted in the context of any particular case.

Notes

Competing interests: None declared.

References

1. Maynard A. Transparency in health technology assessments. BMJ 2007;334:594-5. (24 March.) [PMC free article] [PubMed]

Articles from The BMJ are provided here courtesy of BMJ Publishing Group